Drawing for VENOGLOBULIN

USPTO serial 76217836

VENOGLOBULIN

Reviewed by CopyMark Law Group

Reg. 2717023Status 710
Filing date
Status date
Registration date
May 20, 2003
Examiner
DEFORD, JEFFREY S
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with VENOGLOBULIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations in the nature of gammaglobulin preparations for use in the treatment of primary immunodeficiencies, immune-mediated thrombocytopenia, Kawasaki syndrome, recent bone marrow transplant in adults, chronic B-cell lymphocytic leukemia, pediatric HIV infection, chronic inflammatory demyelinating polyneuropathy, post-transfusion purpura, Guillain-Barre syndrome and chronic inflammatory demyelinating polyneurophathy, anemia because of parvovirus B19, patients with stable multiple myeloma who are at high risk for recurrent infection, cytomegalovirus (CMV)-negative recipients of CMV-positive organs, hypogammaglobulinemic neonates with risk factor for infection or morbidity, intractable epilepsy, systemic vasculitic syndromes, warm-type automimmune hemolytic anemia, neonatal alloimmune thrombocytopenia when unresponsive to other treatments, immune-mediated neutropenia, decompensation in myasthenia gravis, dermatomyositis, polymyosits, thrombocytopenia when severe and unresponsive to other treatmentsSECTION 8 - CANCELLEDFeb 26, 1987

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 26, 2009C8..CANCELLED SEC. 8 (6-YR)
Mar 14, 2008CFITCASE FILE IN TICRS
May 20, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2003NPUBNOTICE OF PUBLICATION
Dec 24, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 24, 2002IUAAUSE AMENDMENT ACCEPTED
Jun 27, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 6, 2002DOCKASSIGNED TO EXAMINER
Feb 25, 2002DOCKASSIGNED TO EXAMINER
Nov 16, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2001AUPCAMENDMENT TO USE PROCESSING COMPLETE
Aug 28, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 2, 2001IUAFUSE AMENDMENT FILED
Jun 28, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance